Towa Pharmaceutical Co Ltd (4553)

Tokyo

Currency in JPY

2,975.0

-25.0(-0.83%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

2,973.0

3,000.0

52 wk Range

2,298.0

3,415.0

4553 Income Statement

Featured here, the Income Statement (earnings report) for Towa Pharmaceutical Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

Total Revenues

aa.aa

154,900

165,615

208,859

227,934

259,594

Total Revenues Growth

aa.aa

+40.33%

+6.92%

+26.11%

+9.13%

+13.89%

Cost Of Revenues

aa.aa

89,448

95,429

136,145

146,551

164,865

Gross Profit

aa.aa

65,452

70,186

72,714

81,383

94,729

Gross Profit Growth

aa.aa

+29.23%

+7.23%

+3.6%

+11.92%

+16.4%

Gross Profit Margin %

aa.aa

42.25%

42.38%

34.81%

35.7%

36.49%

Other Operating Expenses, Total

aa.aa

45,523

51,648

67,199

63,735

71,486

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+32.05%	+13.45%	+30.11%	-5.15%	+12.16%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	10,642	11,488	15,265	13,242	16,212
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	34,881	40,160	51,934	50,493	55,274
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

19,929

18,538

5,515

17,648

23,243

Operating Income Growth

aa.aa

+23.24%

-6.98%

-70.25%

+220%

+31.7%

EBIT Margin %

aa.aa

12.87%

11.19%

2.64%

7.74%

8.95%

Net Interest Expenses

aa.aa

-161

-216

-610

-841

-1,395

Net Interest Expenses Growth

aa.aa

-257.78%

-34.16%

-182.41%

-37.87%

-65.87%

Interest Expense, Total

aa.aa

-190

-230

-635

-947

-1,627

Interest And Investment Income

aa.aa

106

232

Other Non Operating Expenses, Total

aa.aa

1,297

1,520

2,086

2,120

3,043

EBT, Excl. Unusual Items

aa.aa

21,065

19,842

6,991

18,927

24,891

Gain (Loss) On Sale Of Assets

aa.aa

-46

225

230

Other Unusual Items, Total

aa.aa

-2,389

2,870

-2,320

5,529

1,246

EBT, Incl. Unusual Items

aa.aa

18,728

22,245

4,605

24,459

26,329

EBT, Incl. Unusual Items Growth

aa.aa

-9.57%

+18.78%

-79.3%

+431.14%

+7.65%

EBT, Incl. Unusual Items Margin

aa.aa

12.09%

13.43%

2.2%

10.73%

10.14%

Income Tax Expense

aa.aa

4,770

6,331

2,404

8,286

7,343

Net Income to Company

aa.aa

13,958

15,914

2,201

16,173

18,986

Minority Interest

aa.aa

Net Income

aa.aa

13,958

15,914

2,201

16,173

18,986

Net Income Growth

aa.aa

-3.76%

+14.01%

-86.17%

+634.8%

+17.39%

Net Income Margin %

aa.aa

9.01%

9.61%

1.05%

7.1%

7.31%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

13,958

15,914

2,201

16,173

18,986

Basic EPS - Continuing Operations

aa.aa

283.62

323.35

44.72

328.58

385.7

Basic EPS - Continuing Operations Growth

aa.aa

-3.77%

+14.01%

-86.17%

+634.82%

+17.38%

Diluted EPS - Continuing Operations

aa.aa

271.93

316.19

44.72

328.58

385.7

Diluted EPS - Continuing Operations Growth

aa.aa

-0.25%

+16.27%

-85.86%

+634.82%

+17.38%

Basic Weighted Average Shares Outstanding

aa.aa

49.21

49.22

Diluted Weighted Average Shares Outstanding

aa.aa

51.28

50.32

49.22

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

+29.55%

+5.26%

+16.67%

EBITDA

aa.aa

30,354

29,492

24,924

35,536

43,342

EBITDA Growth

aa.aa

+24.12%

-2.84%

-15.49%

+42.58%

+21.97%

EBITDA Margin %

aa.aa

19.6%

17.81%

11.93%

15.59%

16.7%

EBIT

aa.aa

19,929

18,538

5,515

17,648

23,243

* In Millions of JPY (except for per share items)

NSE 30

5,156.20

+3.84

+0.07%

NSE All Share

141,361.77

+113.00

+0.08%

US 30

45,660.50

+95.4

+0.21%

US 500

6,484.40

+3.0

+0.05%

FTSE 100

9,217.25

-38.25

-0.41%

DAX

24,055.42

+1.91

+0.01%

South Africa Top 40

94,470.55

+108.13

+0.11%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	27.10	-0.37%	39.89M
Aradel Holdings	510.00	0.00%	2.81M
First HoldCo	32.80	+0.92%	2.78M
Afriprud	16.80	+1.82%	1.16M
UBA	49.20	-0.61%	781.40K
Zenith Bank	69.85	-0.07%	406.02K
Guaranty Trust Holding	97.00	+2.11%	276.47K

Name	Last	Chg. %	Vol.
Skye Shelter Fund	302.00	+0.15%	416.00
Omatek Ventures	1.32	-8.97%	288.17K
Lasaco Assurance PLC	3.58	+8.48%	122.65K
Nem	31.350	+8.48%	10.44K
Abbey Mortgage Bank	7.05	+8.46%	9.63K
Multverse	11.90	+8.18%	13.78K
Nigerian Exchange	57.70	+7.75%	119.17K

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	1.18K
Thomaswy	2.70	-10.00%	8.51K
Transcorp Power	257.90	-9.98%	4.00K
Etranz	10.800	-0.46%	20.33K
Skyway Aviation Handling Company	87.00	-3.39%	1.01K
Redstarex	12.00	0.00%	9.18K
SCOA Nigeria	6.050	+10.00%	118.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Ellah Lakes	14.90	-0.33%	425.05K
MTN Nigeria	415.50	-4.48%	37.54K
VFD PLC	11.50	+4.55%	96.04K
Mutual Benefits Assurance	4.15	+2.22%	343.93K
Guaranty Trust Holding	97.00	+2.11%	276.47K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A A Aaaaaaaaa Aaa	5,340.00	+46.90%	7,844.46
Aaaaa Aaaaaaaaaaaaa	530.00	+35.68%	719.10
Aaaaa	1,880.00	+30.33%	2,450.20
Aaa Aaaaaa Aaa	149.70	+29.68%	194.13
Aaaa Aaaaa A Aa	70.20	+26.05%	88.49
Aaaaaa Aa Aaaaaa A	609.30	+21.59%	740.85

Name	Last	Upside	Fair Value
A A Aaaaaaaaa Aaa	5,340.00	+46.90%	7,844.46
Aaaaa Aaaaaaaaaaaaa	530.00	+35.68%	719.10
Aaaaa	1,880.00	+30.33%	2,450.20
Aaa Aaaaaa Aaa	149.70	+29.68%	194.13
Aaaa Aaaaa A Aa	70.20	+26.05%	88.49
Aaaaaa Aa Aaaaaa A	609.30	+21.59%	740.85

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Towa Pharmaceutical Co Ltd (4553)

4553 Income Statement

Trending Stocks